期刊文献+

腹水浓缩结合抗菌药物对肝硬化并发腹水感染患者实验室指标影响的研究 被引量:8

Impact of ascites concentration combined with antibiotics on laboratory indexes of liver cirrhosis patients complicated with ascites infection
原文传递
导出
摘要 目的探索腹水浓缩结合抗菌药物对肝硬化并发腹水感染患者实验室指标和疗效的影响。方法选取2015年5月-2017年6月医院接受治疗的152例肝硬化并发腹水感染患者为研究对象,按照随机数表法分为对照组和研究组,对照组采用抗菌药物治疗,研究组在对照组基础上添加腹水浓缩治疗。采集患者血液并检测谷丙转氨酶(ALT)、谷草转氨酶(AST)、尿素氮(BUN)、总胆红素(TBIL)、血肌酐(Scr)等实验室指标。采用肝硬化腹水中西医结合诊疗评价量表对患者疗效进行评价。结果研究组患者治疗后ALT为(41.07±12.11)IU/L,AST为(34.28±10.44)IU/L,BUN为(4.12±1.03)mmol/L,TBIL为(30.47±11.29)μmol/L,Scr为(89.24±17.67)μmol/L,均低于对照组患者ALT(58.13±13.24)IU/L,AST(63.22±13.47)IU/L,BUN(7.13±2.37)mmol/L,TBIL(47.82±13.43)μmol/L,Scr(125.08±27.69)μmol/L(P<0.05)。两组疗效等级资料比较差异无统计学意义,但研究组患者治疗总有效率94.74%(72/76)高于对照组总有效率76.32%(58/76),两组比较差异有统计学意义(χ^2=10.417,P<0.001)。结论腹水浓缩结合抗菌药物能够有效降低肝硬化并发腹水感染患者实验室指标水平,治疗效果显著,适合临床推广治疗。 OBJECTIVE To observe the effect of ascites concentration combined with antibiotics on laboratory indexes and curative effects of the liver cirrhosis patients complicated with ascites infection.METHODS A total of 152 liver cirrhosis patients complicated with ascites infection who were treated in the hospital from May 2015 to Jun2017 were recruited as the study objects and randomly divided into the control group and the study group.The control group was treated with antibiotics,while the study group was given the ascites concentration therapy on basis of the treatment of the control group.The blood specimens were collected to detect the laboratory indexes,including alanine aminotransferase(ALT),aspartate aminotransferase(AST),blood urea nitrogen(BUN),total bilirubin(TBIL)and serum creatinine(Scr).The curative effects of the patients were evaluated on the basis of Traditional Chinese Medicine combined with western medicine evaluation scale for liver cirrhosis-induced ascites.RESULTS The levels of ALT,AST,BUN,TBIL and Scr of the study group were respectively(41.07±12.11)IU/L,(34.28±10.44)IU/L,(4.12±1.03)mmol/L,(30.47±11.29)μmol/L and(89.24±17.67)μmol/L after the treatment,significantly lower than(58.13±13.24)IU/L,(63.22±13.47)IU/L,(7.13±2.37)mmol/L,(47.82±13.43)μmol/L and(125.08±27.69)μmol/L of the control group(P<0.05).There was no significant difference in the curative effect classification data between the two groups,however,the total effective rate of treatment of the study group was 94.74%(72/76),significantly higher than 76.32%(58/76)of the control group(χ^2=10.417,P<0.001).CONCLUSIONThe ascites concentration combined with antibiotics can effectively reduce the levels of laboratory indexes of the liver cirrhosis patients complicated with ascites infection and achieve remarkable curative effect,and it is worthy to be promoted in the hospital.
作者 赵先胜 翁伦华 程寄吾 慎强 周薇 ZHAO Xian-sheng;WENG Lun-hua;CHENG Ji-wu;SHEN Qiang;ZHOU Wei(Ningbo Second Hospital,Ningbo,Zhejiang 315000,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2019年第1期75-77,87,共4页 Chinese Journal of Nosocomiology
基金 浙江省医药卫生一般研究基金资助项目(20151123)
关键词 腹水浓缩 抗菌药物 肝硬化并发腹水感染 实验室指标 Ascites concentration Antibiotic Liver cirrhosis complicated with ascites infection Laboratory index
  • 相关文献

参考文献6

二级参考文献39

  • 1Sandra Braun,Christoph Berg,Sandra Buck,Michael Gregor,Reinhild Klein.Catalytic domain of PDC-E2 contains epitopes recognized by antimitochondrial antibodies in primary biliary cirrhosis[J].World Journal of Gastroenterology,2010,16(8):973-981. 被引量:13
  • 2Si-Biao Su,Shan-Yu Qin,Xiao-Yun Guo,Wei Luo,Hai-Xing Jiang.Assessment by meta-analysis of interferon-gamma for the diagnosis of tuberculous peritonitis[J].World Journal of Gastroenterology,2013,19(10):1645-1651. 被引量:17
  • 3Iloeje UH,Yang HI,Su J,陆伟(摘译),张占卿(审校).根据循环乙型肝炎病毒载量预测肝硬化的危险性[J].世界感染杂志,2006,6(4):396-396. 被引量:211
  • 4Rimola A, Garda-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club[J]. J Hepatol, 2000, 32 (1) : 142 -153.
  • 5Campillo B, Richardet JP, Kheo T, et al. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients : impact of isolate type on prognosis and characteristics ofinfection[J]. ClinInfect Dis, 2002,35(1):1- 10.
  • 6Guler K, Vatansever S, Kayacan SM, et al. High sensitivity C reactive protein in spontaneous bacterial peritonitis with nonneutrocytic ascites [J]. Hepatogastroenterology, 2009, 56(90) :452 -455.
  • 7Yuan LY, Ke ZQ, Wang M,et al. Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B[J]. Ann Lab Med, 2013,33(6):449 454. DOI: 10. 3343/aim. 2013. 33.6. 449.
  • 8Cai ZH, Fan CL, Zheng JF, et al. Measurement of serum procalcitonin levels for the early diagnosis of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis[J/Ol]. BMClnfect Dis, 2015,15:55[2015 -02-13[ http:// bmcinfectdis, biomedcentral, corn/articles/10. 1186/ s12879-015 0776 4. DOI.- 10.1186/s12879 015-0776-4.
  • 9D'Amico G, De Franchis R, Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post therapeutic outcome and prognostic indicators[J].Hepatology, 2003,38 (3) : 599-612. DOI: 10.1053/jhep. 2003. 50385.
  • 10Hung TH, Tsai CC, Hsieh YH, et al. The long-termmortality of spontaneous bacterial peritonitis in cirrhotic patients: a 3 year nationwide cohort study [J]. Turk J Gastroenterol, 2015, 26 (2):159 -162. DOI: 10. 5152/tjg. 2015. 4829.

共引文献87

同被引文献91

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部